ArticleBMC pregnancy and childbirth2025
Ultrasonographic clues to malignancy: a decade of adnexal mass evaluation in pregnant women.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe discovery of adnexal masses during pregnancy is being reported more often due to the greater use of prenatal ultrasonography, which leads to important clinical choices that can affect both the mother and the fetus. Although most of these masses are benign, a small proportion are malignant. Accurate diagnosis and management are therefore critical for maternal and fetal prognosis.
methodsThis retrospective study included 152 pregnant patients diagnosed with an ovarian mass between January 2015 and December 2024 at a tertiary care center. We divided the patients into two groups: observation (n = 92) and surgery (n = 60). The surgical group was further classified as benign, borderline, or malignant based on histopathological findings. We examined the ultrasound characteristics, including the size of the mass, solid parts, finger-like growths, cyst shape, and personal evaluations. We performed the statistical analysis using SPSS version 22.0, considering a p-value of less than 0.05 as statistically significant.
resultsAmong the 60 patients who underwent surgery, 45% had benign tumors, 33.3% had borderline tumors, and 21.7% had malignant tumors. The median tumor diameter in malignant cases was 115 mm, which was significantly larger than in other groups (p = 0.0001). Malignant masses were more frequently multilocular or solid in nature (p < 0.001). The size of the solid component and the presence of papillary projections were also significantly associated with malignancy (p = 0.0007 and p = 0.002, respectively). Subjective ultrasound assessment showed a high concordance in predicting malignancy.
conclusionsMorphological feature characteristics such as tumor diameter, the presence of papillary projections, and solid components observed on ultrasonography are strong predictors of malignancy. Therefore, it is important to consider these factors. It’s important to carefully examine adnexal masses with ultrasound and involve different specialists when managing these issues during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.